Company: FVN
Filing Date: 2025-04-14
Form Type: DRS/A
Source: 0001829126-25-002616
Chunk: 167

Company: Future Vision II Acquisition Corp.
Filing Date: 2025-04-14
Form: DRS/A
Chunk 167
---
 including:

| ● | adverse actions taken by regulatory agencies with respect to our products;                                                                                                                                                                          |
| ● | announcements of technological innovations, patents or new products by our competitors;                                                                                                                                                             |
| ● | regulatory developments in the United States and foreign countries;                                                                                                                                                                                 |
| ● | any lawsuit involving us or our product candidates;                                                                                                                                                                                                 |
| ● | announcements concerning our competitors, or the industry in which we compete in general;                                                                                                                                                           |
| ● | developments concerning any strategic alliances or acquisitions we may enter into;                                                                                                                                                                  |
| ● | actual or anticipated variations in our operating results;                                                                                                                                                                                          |
| ● | changes in recommendations by securities analysts or lack of analyst coverage;                                                                                                                                                                      |
| ● | deviations in our operating results from the estimates of analysts;                                                                                                                                                                                 |
| ● | our inability, or the perception by investors that we will be unable, to continue to meet all applicable requirements for continued listing of our ordinary shares on the Nasdaq Capital Market, and the possible delisting of our ordinary shares; |
| ● | sales of our ordinary shares by our executive officers, directors and principal Shareholders or sales of substantial amounts of Ordinary Share; and                                                                                                 |
| ● | loss of any of our key management personnel.                                                                                                                                                                                                        |

In the past, following periods of volatility in the market price of a particular company’s securities, litigation has often been brought against that company. Any such lawsuit could consume resources and management time and attention, which could adversely affect our business.

If the Business Combination’s benefits do not meet the expectations of investors or securities analysts, the market price of our securities may decline.

If the benefits of the Business Combination do not meet the expectations of investors or securities analysts, the market price of our securities may decline. The market values of our securities at the time of the Business Combination may vary significantly from their prices on the date the Merger Agreement was executed, the date of this proxy statement, or the date on which our Shareholders vote on the Business Combination.

<div align='center'>92</div>

In addition, following the Business Combination, fluctuations in the price of our securities could contribute to the loss of all or part of your investment. Prior to the Business Combination, there has not been a public market for VIWO’s securities. Accordingly, the valuation ascribed to VIWO’s ordinary shares in the Business Combination may not be indicative of the actual price that will prevail in the trading market following the Business Combination. If an active market for our securities develops and continues, the trading price of our